13 May, 2026 | Wednesday | News

Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene therapies, ProBio Inc. and Curocell have achieved a signi...

14 May, 2026 | Thursday | News

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. Isomorphic Labs, an AI-first drug design and develop...

14 May, 2026 | Thursday | News

New kit offers researchers and development teams a meaningful advance in expression speed and output GenScript Biotech Corporation announced the launch of TurboCHO™ Protein Expression Kit, a ne...

06 May, 2026 | Wednesday | News

Small by design, built for the demands of modern genetic medicine across gene therapy, cell therapy, and vaccines  VectorBuilder, a global leader in gene delivery technologies and CDMO services,  ann...

11 May, 2026 | Monday | News

As hearing care evolves beyond conventional amplification models, personalisation is emerging as a critical factor in improving patient outcomes and long term device adoption. In this exclusiv...

15 May, 2026 | Friday | News

Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has approved INQOVI (decitabine and cedazuridine) plus venetoclax as a treatment for adults wi...

13 May, 2026 | Wednesday | News

Porton Advanced, a premier contract development and manufacturing organization (CDMO) specializing in Advanced Therapy Medicinal Products (ATMPs), and Dark Horse Consulting Group ("DHCG" or "the Group"), a lead...